CRISPR Therapeutics Grants CMO 24,000 Stock Options and 12,000 RSUs
CRISPR Therapeutics granted Chief Medical Officer Naimish Patel 24,000 stock options and 12,000 restricted stock units.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
CRISPR Therapeutics granted Chief Medical Officer Naimish Patel 24,000 stock options and 12,000 restricted stock units.